ADVIL COLD AND SINUS Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Advil Cold And Sinus, and what generic alternatives are available?
Advil Cold And Sinus is a drug marketed by Haleon Us Holdings and is included in two NDAs.
The generic ingredient in ADVIL COLD AND SINUS is ibuprofen; pseudoephedrine hydrochloride. There are sixty-four drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the ibuprofen; pseudoephedrine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Advil Cold And Sinus
A generic version of ADVIL COLD AND SINUS was approved as ibuprofen; pseudoephedrine hydrochloride by DR REDDYS LABS LTD on August 14th, 2006.
Summary for ADVIL COLD AND SINUS
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 2 |
| Patent Applications: | 2 |
| Formulation / Manufacturing: | see details |
| What excipients (inactive ingredients) are in ADVIL COLD AND SINUS? | ADVIL COLD AND SINUS excipients list |
| DailyMed Link: | ADVIL COLD AND SINUS at DailyMed |
Pharmacology for ADVIL COLD AND SINUS
| Drug Class | Nonsteroidal Anti-inflammatory Drug alpha-Adrenergic Agonist |
| Mechanism of Action | Adrenergic alpha-Agonists Cyclooxygenase Inhibitors |
Anatomical Therapeutic Chemical (ATC) Classes for ADVIL COLD AND SINUS
US Patents and Regulatory Information for ADVIL COLD AND SINUS
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Haleon Us Holdings | ADVIL COLD AND SINUS | ibuprofen; pseudoephedrine hydrochloride | CAPSULE;ORAL | 021374-001 | May 30, 2002 | OTC | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Haleon Us Holdings | ADVIL COLD AND SINUS | ibuprofen; pseudoephedrine hydrochloride | TABLET;ORAL | 019771-001 | Sep 19, 1989 | OTC | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ADVIL COLD AND SINUS
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Haleon Us Holdings | ADVIL COLD AND SINUS | ibuprofen; pseudoephedrine hydrochloride | TABLET;ORAL | 019771-001 | Sep 19, 1989 | ⤷ Try a Trial | ⤷ Try a Trial |
| Haleon Us Holdings | ADVIL COLD AND SINUS | ibuprofen; pseudoephedrine hydrochloride | CAPSULE;ORAL | 021374-001 | May 30, 2002 | ⤷ Try a Trial | ⤷ Try a Trial |
| Haleon Us Holdings | ADVIL COLD AND SINUS | ibuprofen; pseudoephedrine hydrochloride | CAPSULE;ORAL | 021374-001 | May 30, 2002 | ⤷ Try a Trial | ⤷ Try a Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ADVIL COLD AND SINUS
See the table below for patents covering ADVIL COLD AND SINUS around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Japan | H07116021 | ⤷ Try a Trial | |
| Japan | H01503539 | ⤷ Try a Trial | |
| South Africa | 8502485 | ⤷ Try a Trial | |
| Japan | 2848556 | ⤷ Try a Trial | |
| Australia | 2029195 | ⤷ Try a Trial | |
| Germany | 3772760 | ⤷ Try a Trial | |
| Australia | 1687388 | ⤷ Try a Trial | |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
